Manual zur indikation und durchführung der echokardiographie
T Buck, OA Breithardt, L Faber, W Fehske… - Clinical research in …, 2009 - Springer
Das vorliegende Manual gibt auf Grundlage der aktuellen wissenschaftlichen Literatur den
Konsens einer Expertengruppe zum Indikationsspektrum, zur praktischen Durchführung und …
Konsens einer Expertengruppe zum Indikationsspektrum, zur praktischen Durchführung und …
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial
GM Buyse, N Goemans, M van den Hauwe… - Neuromuscular …, 2011 - Elsevier
Early mortality in Duchenne muscular dystrophy (DMD) is related to cardiac and respiratory
complications. A phase IIa double-blind randomized placebo-controlled clinical trial was …
complications. A phase IIa double-blind randomized placebo-controlled clinical trial was …
[HTML][HTML] Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs
DW Townsend, I Turner, S Yasuda… - The Journal of …, 2010 - Am Soc Clin Investig
Duchenne muscular dystrophy (DMD) is a fatal disease of striated muscle deterioration
caused by lack of the cytoskeletal protein dystrophin. Dystrophin deficiency causes muscle …
caused by lack of the cytoskeletal protein dystrophin. Dystrophin deficiency causes muscle …
Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging
MW Ashford Jr, W Liu, SJ Lin, P Abraszewski… - Circulation, 2005 - Am Heart Assoc
Background—Duchenne muscular dystrophy (DMD) is an inherited disease characterized
by early onset of skeletal muscle degeneration and progressive weakness. Although dilated …
by early onset of skeletal muscle degeneration and progressive weakness. Although dilated …
Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy
BACKGROUND: In young patients (aged< 12 years) with Duchenne muscular dystrophy
(DMD), cardiac systolic function is generally described to be within the normal range. Recent …
(DMD), cardiac systolic function is generally described to be within the normal range. Recent …
Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy
DS Jassal, SY Han, C Hans, A Sharma, T Fang… - Journal of the American …, 2009 - Elsevier
BACKGROUND: Trastuzumab provides considerable therapeutic benefits in the adjuvant
setting of breast cancer. However, its use is limited by an elevated incidence of cardiotoxicity …
setting of breast cancer. However, its use is limited by an elevated incidence of cardiotoxicity …
Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension
CC Sampedrano, V Chetboul, V Gouni… - Journal of Veterinary …, 2006 - Wiley Online Library
Background: Hypertrophic Cardiomyopathy (HCM) and chronic systemic hypertension (SHT)
can both lead to left‐ventricular hypertrophy (LVH) in cats. Assessment of LVH‐associated …
can both lead to left‐ventricular hypertrophy (LVH) in cats. Assessment of LVH‐associated …
Radial strain and strain rate by two-dimensional speckle tracking echocardiography and the tissue velocity based technique in the dog
V Chetboul, F Serres, V Gouni, R Tissier… - Journal of veterinary …, 2007 - Elsevier
OBJECTIVES: Two-dimensional (2D) speckle tracking echocardiography (STE) is a new
angle-independent ultrasound technique based on tracking of speckles within the …
angle-independent ultrasound technique based on tracking of speckles within the …
Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy
NK Lakdawala, JJ Thune, SD Colan… - Circulation …, 2012 - Am Heart Assoc
Background—Sarcomere mutations cause both dilated cardiomyopathy (DCM) and
hypertrophic cardiomyopathy (HCM); however, the steps leading from mutation to disease …
hypertrophic cardiomyopathy (HCM); however, the steps leading from mutation to disease …
[HTML][HTML] Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping
LT Bish, MM Sleeper, SC Forbes, B Wang, C Reynolds… - Molecular Therapy, 2012 - cell.com
Although restoration of dystrophin expression via exon skipping in both cardiac and skeletal
muscle has been successfully demonstrated in the mdx mouse, restoration of cardiac …
muscle has been successfully demonstrated in the mdx mouse, restoration of cardiac …